Numarck Medicals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 20-12-2024
- Paid Up Capital ₹ 0.50 M
as on 20-12-2024
- Company Age 7 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.00 M
as on 20-12-2024
- Satisfied Charges ₹ 1.00 M
as on 20-12-2024
- Revenue 77.90%
(FY 2022)
- Profit 100.05%
(FY 2022)
- Ebitda 103.61%
(FY 2022)
- Net Worth 1.19%
(FY 2022)
- Total Assets -16.40%
(FY 2022)
About Numarck Medicals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹3.00 M. The company has closed loans amounting to ₹1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Viveak Kaul and Santosh Kaul serve as directors at the Company.
- CIN/LLPIN
U33129DL2017PTC313460
- Company No.
313460
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Feb 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Numarck Medicals Private Limited offer?
Numarck Medicals Private Limited offers a wide range of products and services, including Cosmetics, Hair & Beauty Products, Skin Care Cosmetics.
Who are the key members and board of directors at Numarck Medicals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Viveak Kaul  | Director | 27-Feb-2017 | Current |
| Santosh Kaul | Director | 27-Feb-2017 | Current |
Financial Performance of Numarck Medicals.
Numarck Medicals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 77.9% increase. The company also saw a substantial improvement in profitability, with a 100.05% increase in profit. The company's net worth moved up by a moderate rise of 1.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Numarck Medicals?
Unlock access to Numarck Medicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
₹3.00 M
₹1.00 M
Charges Breakdown by Lending Institutions
- Others : 0.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Jan 2019 | Others | ₹3.00 M | Open |
| 16 Dec 2017 | Others | ₹1.00 M | Satisfied |
How Many Employees Work at Numarck Medicals?
Unlock and access historical data on people associated with Numarck Medicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Numarck Medicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Numarck Medicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.